Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort
Contributeurs/tricesPittet, V.; Juillerat, P.; Michetti, P.; Vader, John-Paul; Burnand, Bernard; Rogler, G.; Beglinger, C.; Seibold, F.; Mottet, C.; Felley, Christian; Gonvers, J-J; Froehlich, F.; Swiss IBD Cohort Study Group
Collaborateurs/tricesTempia-Caliera Schaeppi, Michela
Publié dansAlimentary pharmacology & therapeutics, no. 8, p. 1007-1016
Date de publication2010
Résumé
Mots-clés
- Adult
- Antibodies, Monoclonal/therapeutic use
- Cohort Studies
- Crohn Disease/*complications/drug therapy/surgery/*therapy
- Cross-Sectional Studies
- Female
- Fistula/*therapy
- Gastrointestinal Agents/therapeutic use
- Humans
- Immunosuppressive Agents/therapeutic use
- Male
- Middle Aged
- Quality Assurance, Health Care/methods
- Tumor Necrosis Factor-alpha/therapeutic use
- Young Adult
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
PITTET, V. et al. Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort. In: Alimentary pharmacology & therapeutics, 2010, n° 8, p. 1007–1016. doi: 10.1111/j.1365-2036.2010.04434.x
Fichiers principaux (1)
Article
Identifiants
- PID : unige:21217
- DOI : 10.1111/j.1365-2036.2010.04434.x
- PMID : 20937046
ISSN du journal0269-2813